BWM
AMPE

BT Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

BT Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-83
Closed -$24K – 67
2020
Q3 		$24K Buy
+83
New +$20.6K 0.01% 59

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BT Wealth Management's AMPE Position: Q4 2020 in Review

BT Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2020, closing a stake of 83 shares — an estimated $24K sold.

BT Wealth Management first reported a position in AMPE in Q3 2020 and held it in 1 quarter. The position peaked at $24K in Q3 2020. 103 funds tracked by Wall St. Rank hold AMPE as of Q4 2020.

  • BT Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2020 after selling out during the quarter.
  • BT Wealth Management sold 83 Ampio Pharmaceuticals Inc. shares in Q4 2020, an estimated $24K.
  • BT Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and held it in 1 quarter.
  • BT Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $24K in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2020.

Based on BT Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.